Compile Data Set for Download or QSAR
Report error Found 37 Enz. Inhib. hit(s) with all data for entry = 50004890
TargetVasopressin V1a receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029649(L-371257 | 1-(1-(4-(1-acetylpiperidin-4-yloxy)-2-m...)
Affinity DataKi:  3.70nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liverMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029649(L-371257 | 1-(1-(4-(1-acetylpiperidin-4-yloxy)-2-m...)
Affinity DataKi:  4.60nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V1a receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029646(1-{1-[4-(1-Acetyl-piperidin-4-yloxy)-benzoyl]-pipe...)
Affinity DataKi:  5.60nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liverMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V1a receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029643(1-(1-{4-[2-(1-Acetyl-piperidin-2-yl)-ethoxy]-benzo...)
Affinity DataKi:  15nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liverMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetOxytocin receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029649(L-371257 | 1-(1-(4-(1-acetylpiperidin-4-yloxy)-2-m...)
Affinity DataKi:  19nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V1a receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029647(1-{1-[4-(1-Acetyl-piperidin-3-ylmethoxy)-benzoyl]-...)
Affinity DataKi:  24nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liverMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029646(1-{1-[4-(1-Acetyl-piperidin-4-yloxy)-benzoyl]-pipe...)
Affinity DataKi:  24nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V1a receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029648(N-(3-{4-[4-(2-Oxo-4H-benzo[d][1,3]oxazin-1-yl)-pip...)
Affinity DataKi:  31nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V1a receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029644(N-(3-(4-(4-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)pip...)
Affinity DataKi:  32nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetOxytocin receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029646(1-{1-[4-(1-Acetyl-piperidin-4-yloxy)-benzoyl]-pipe...)
Affinity DataKi:  69nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029648(N-(3-{4-[4-(2-Oxo-4H-benzo[d][1,3]oxazin-1-yl)-pip...)
Affinity DataKi:  130nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from human....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetOxytocin receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029643(1-(1-{4-[2-(1-Acetyl-piperidin-2-yl)-ethoxy]-benzo...)
Affinity DataKi:  130nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029643(1-(1-{4-[2-(1-Acetyl-piperidin-2-yl)-ethoxy]-benzo...)
Affinity DataKi:  150nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029644(N-(3-(4-(4-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)pip...)
Affinity DataKi:  170nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from human....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029647(1-{1-[4-(1-Acetyl-piperidin-3-ylmethoxy)-benzoyl]-...)
Affinity DataKi:  200nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetOxytocin receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029648(N-(3-{4-[4-(2-Oxo-4H-benzo[d][1,3]oxazin-1-yl)-pip...)
Affinity DataKi:  200nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetOxytocin receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029644(N-(3-(4-(4-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)pip...)
Affinity DataKi:  230nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetOxytocin receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029647(1-{1-[4-(1-Acetyl-piperidin-3-ylmethoxy)-benzoyl]-...)
Affinity DataKi:  340nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V1a receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029645(N-(3-{4-[4-(2-Oxo-3,4-dihydro-2H-quinazolin-1-yl)-...)
Affinity DataKi: >1.00E+3nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetOxytocin receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029645(N-(3-{4-[4-(2-Oxo-3,4-dihydro-2H-quinazolin-1-yl)-...)
Affinity DataKi:  2.10E+3nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from human....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetOxytocin receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029645(N-(3-{4-[4-(2-Oxo-3,4-dihydro-2H-quinazolin-1-yl)-...)
Affinity DataKi:  2.40E+3nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V2 receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029645(N-(3-{4-[4-(2-Oxo-3,4-dihydro-2H-quinazolin-1-yl)-...)
Affinity DataKi: >3.00E+3nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in kidney medulla obtained...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V1a receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029649(L-371257 | 1-(1-(4-(1-acetylpiperidin-4-yloxy)-2-m...)
Affinity DataKi:  3.20E+3nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human plateletsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V2 receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029643(1-(1-{4-[2-(1-Acetyl-piperidin-2-yl)-ethoxy]-benzo...)
Affinity DataKi:  1.10E+4nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]-AVP (arginine vasopressin) from specific binding sites in kidney medulla obtaine...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V2 receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029647(1-{1-[4-(1-Acetyl-piperidin-3-ylmethoxy)-benzoyl]-...)
Affinity DataKi:  1.10E+4nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]-AVP (arginine vasopressin) from specific binding sites in kidney medulla obtaine...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V1a receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029646(1-{1-[4-(1-Acetyl-piperidin-4-yloxy)-benzoyl]-pipe...)
Affinity DataKi:  1.20E+4nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human plateletsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V1a receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029643(1-(1-{4-[2-(1-Acetyl-piperidin-2-yl)-ethoxy]-benzo...)
Affinity DataKi:  2.20E+4nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human plateletsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V2 receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029644(N-(3-(4-(4-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)pip...)
Affinity DataKi: >3.00E+4nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in kidney medulla obtained...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V2 receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029649(L-371257 | 1-(1-(4-(1-acetylpiperidin-4-yloxy)-2-m...)
Affinity DataKi: >3.00E+4nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]-AVP (arginine vasopressin) from specific binding sites in kidney medulla obtaine...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V2 receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029648(N-(3-{4-[4-(2-Oxo-4H-benzo[d][1,3]oxazin-1-yl)-pip...)
Affinity DataKi:  3.50E+4nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in kidney medulla obtained...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V2 receptor(Rat)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029646(1-{1-[4-(1-Acetyl-piperidin-4-yloxy)-benzoyl]-pipe...)
Affinity DataKi:  3.50E+4nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]-AVP (arginine vasopressin) from specific binding sites in kidney medulla obtaine...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V1a receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029648(N-(3-{4-[4-(2-Oxo-4H-benzo[d][1,3]oxazin-1-yl)-pip...)
Affinity DataKi:  3.60E+4nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V2 receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029649(L-371257 | 1-(1-(4-(1-acetylpiperidin-4-yloxy)-2-m...)
Affinity DataKi:  3.70E+4nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]-AVP (arginine vasopressin) from specific binding sites in kidney medulla obtaine...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V1a receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029647(1-{1-[4-(1-Acetyl-piperidin-3-ylmethoxy)-benzoyl]-...)
Affinity DataKi:  3.80E+4nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human plateletsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V1a receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029644(N-(3-(4-(4-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)pip...)
Affinity DataKi:  5.20E+4nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V1a receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029645(N-(3-{4-[4-(2-Oxo-3,4-dihydro-2H-quinazolin-1-yl)-...)
Affinity DataKi:  6.20E+4nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVasopressin V2 receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50029644(N-(3-(4-(4-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)pip...)
Affinity DataKi: >8.10E+4nMAssay Description:Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in kidney medulla obtained...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed